Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Inventory

v3.21.1
Note 6 - Inventory
3 Months Ended
Mar. 31, 2021
Notes to Financial Statements  
Inventory Disclosure [Text Block]
6.
Inventory
 
The components of inventory as of
March 31, 2021
and
December 31, 2020
are as follows:
 
   
March 31, 2021
   
December 31, 2020
 
Materials
  $
77,750
    $
77,750
 
Finished goods
   
88,492
     
92,048
 
Total inventory
  $
166,242
    $
169,798
 
 
During the
three
-month period ended
March 31, 2021,
we allocated
$4,000
of finished goods inventory for use in clinical trials. This transaction was recorded in research and development expense in the consolidated statements of operations.